AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -71.4% | 1,457 | -73.3% | 0.00% | -66.7% |
| Q2 2023 | $21 | -47.5% | 5,453 | -68.0% | 0.00% | -25.0% |
| Q1 2023 | $40 | +135.3% | 17,047 | +181.4% | 0.00% | +300.0% |
| Q4 2022 | $17 | -99.9% | 6,058 | +7.1% | 0.00% | -50.0% |
| Q3 2022 | $24,000 | -90.0% | 5,658 | -81.4% | 0.00% | -88.2% |
| Q2 2022 | $241,000 | -37.2% | 30,340 | -70.4% | 0.02% | -15.0% |
| Q1 2022 | $384,000 | -80.3% | 102,613 | -61.7% | 0.02% | -75.6% |
| Q4 2021 | $1,945,000 | +45.9% | 267,592 | +45.6% | 0.08% | +36.7% |
| Q3 2021 | $1,333,000 | +832.2% | 183,833 | +376.3% | 0.06% | +757.1% |
| Q2 2021 | $143,000 | +615.0% | 38,600 | +841.5% | 0.01% | – |
| Q1 2021 | $20,000 | -77.8% | 4,100 | -78.0% | 0.00% | -100.0% |
| Q4 2020 | $90,000 | +57.9% | 18,600 | +30.1% | 0.00% | 0.0% |
| Q3 2020 | $57,000 | -25.0% | 14,300 | -32.5% | 0.00% | -20.0% |
| Q2 2020 | $76,000 | +90.0% | 21,200 | +17.8% | 0.01% | +150.0% |
| Q1 2020 | $40,000 | -77.1% | 18,000 | -40.8% | 0.00% | -81.8% |
| Q4 2019 | $175,000 | +386.1% | 30,400 | +226.9% | 0.01% | +266.7% |
| Q3 2019 | $36,000 | 0.0% | 9,300 | +69.1% | 0.00% | 0.0% |
| Q2 2019 | $36,000 | +24.1% | 5,500 | -5.2% | 0.00% | 0.0% |
| Q1 2019 | $29,000 | -9.4% | 5,800 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $32,000 | +300.0% | 5,600 | -48.1% | 0.00% | +200.0% |
| Q3 2018 | $8,000 | +14.3% | 10,800 | +2.9% | 0.00% | – |
| Q2 2018 | $7,000 | +133.3% | 10,500 | +94.4% | 0.00% | – |
| Q1 2018 | $3,000 | -76.9% | 5,400 | -42.6% | 0.00% | – |
| Q4 2017 | $13,000 | -89.2% | 9,400 | -90.4% | 0.00% | -100.0% |
| Q3 2017 | $120,000 | -75.1% | 97,500 | -49.3% | 0.00% | -76.5% |
| Q2 2017 | $481,000 | -2.6% | 192,341 | -2.5% | 0.02% | -15.0% |
| Q1 2017 | $494,000 | +24600.0% | 197,240 | +13988.6% | 0.02% | – |
| Q4 2016 | $2,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
| NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
| Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
| Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
| HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
| Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
| Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |